Therapeutic Opportunities in Cardiometabolic Disease

The Lipoprotein Metabolism GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field. If you want your abstract to be considered for a short talk, please register and submit your abstract no later than Sunday, May 10th, 2026. The 2026 Gordon Research Conference (GRC) on Lipoprotein Metabolism will be held at Waterville Valley Conference Center, NH, from June 7-12, 2026. As in previous GRC meetings on this topic, this meeting will focus on the latest cutting-edge and unpublished findings on the role of lipid and lipoprotein metabolism in cardiometabolic and neurodegenerative diseases. We are excited to also include sessions focused on new directions for therapeutic approaches that are fueled by novel basic science insights. The Co-Chairs, Drs. Thomas Vallim and J. Mark Brown, in consultation with the past chairs, the 2026 Vice Chairs (Drs. Elizabeth Tarling and Sean Davidson), and subject matter experts, have developed a conference program that includes a diverse range of discussion leaders, as well as established and emerging scientists in the area of lipoprotein metabolism from institutions worldwide. The Keynote presentations will be on the cell biology of lipid storage (presented by Drs. Tobias Walther and Robert Farese – Sloan Kettering Institute). and mechanisms underlying metabolic dysfunction-associated steatotic liver disease (presented by Dr. Jay Horton – University of Texas Southwestern Medical Center) Several short talks are arranged in different sessions that include the rich history of the lipoprotein metabolism GRC, lipoprotein metabolism and cardiometabolic disease, intra-organelle biology of lipid and lipoprotein metabolism, in vivo physiology of lipid & lipoprotein metabolism, therapeutic interventions for lipid and lipoprotein metabolism, interplay between bile acids, microbiome and lipoprotein metabolism, lipoprotein structure and function, lipoprotein metabolism in neurodegenerative disease, and emerging concepts in metabolic dysfunction-associated steatotic liver disease (MASLD). The GRC will be preceded by the GRS on Lipoprotein Metabolism, an international forum for presentation and discussion of new frontiers in lipoprotein metabolism research by graduate students and postdoctoral fellows.